Cancer Vaccines Market Report 2024: 5 Breakthrough Immunotherapy Trends, Pipeline Analysis, Market Size & Global Forecast Through 2032
8 mRNA Cancer Vaccine Trials Advancing Through Global Oncology Pipelines in 2026
The United States National Cancer Institute's 2026 Annual Report to the Nation, released in January, identifies mRNA-based therapeutic vaccines as the fastest-growing category in the US oncology pipeline — with 34 active investigational new drug applications filed in the 12 months ending December 2025, a...
0 Комментарии
0 Поделились
633 Просмотры
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt